Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Moligand™, ≥98% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
BV-6 is a SMAC mimetic, dualcIAPandXIAPinhibitor.
Targets
cIAP ; XIAP
In vitro
BV6 inhibits the cell viability of HCC193 NSCLC cells with IC50 of 7.2 μM, induces apoptosis in both HCC193 and H460 cell lines, and also significantly enhances the radiosensitivity of these cell lines through activation of cleaved caspase-8 and cleaved caspase-9, respectively. In immature dendritic cells, BV-6 treatment results in moderate activation of the classical NF-kB pathway. Furthermore, BV-6 increases CIK cell-mediated lysis of hematological (H9, THP-1, and Tanoue) and solid malignancies (RH1, RH30, and TE671). BV-6 also enhances apoptosis of peripheral blood mononuclear cells and most notably has an inhibitory effect on immune cells limiting their cytotoxic potential.
Cell Research(from reference)
Cell lines:HCC193 and H460 cells
Concentrations:~30 μM
Incubation Time:~48 hours
| Pubchem Sid | 488200364 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488200364 |
| Sonrisas canónicas | CNC(C)C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C(=O)NC(C(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)NCCCCCCNC(=O)C(NC(=O)C5CCCN5C(=O)C(NC(=O)C(C)NC)C6CCCCC6)C(C7=CC=CC=C7)C8=CC=CC=C8 |
| Peso molecular | 1205.57(free) |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Fecha | Articulo |
|---|---|---|---|
| Certificate of Analysis | Jan 21, 2026 | B413788 | |
| Certificate of Analysis | Jan 21, 2026 | B413788 | |
| Certificate of Analysis | Jan 21, 2026 | B413788 | |
| Certificate of Analysis | Jan 21, 2026 | B413788 | |
| Certificate of Analysis | Jan 21, 2026 | B413788 | |
| Certificate of Analysis | Jan 21, 2026 | B413788 | |
| Certificate of Analysis | Jan 21, 2026 | B413788 | |
| Certificate of Analysis | Jan 21, 2026 | B413788 |
| Solubilidad | Solubility (25°C) In vitro DMSO: 100 mg/mL (82.94 mM); Water: 100 mg/mL (82.94 mM); Ethanol: 100 mg/mL warmed with 50ºC Water: bath (82.94 mM); |
|---|
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →